CHIPPING CAMPDEN SURGERY
BACK ENDS, CHIPPING CAMPDEN
AF007
In those patients with atrial fibrillation with a record of a CHA2DS2-VASc score of 2 or more, the percentage of patients who are currently treated with anticoagulation drug therapy
| Indicator | Year | Numerator | Denominator | Ratio | Centile |
|---|---|---|---|---|---|
| AF 6 | 2013 | 34 | 36 | 94.4% | |
| AF003 | 2014 | 37 | 37 | 100.0% | |
| AF005 | 2015 | 34 | 34 | 100.0% | |
| AF007 | 2016 | 113 | 119 | 95.0% | |
| AF007 | 2017 | 124 | 132 | 93.9% | |
| AF007 | 2018 | 123 | 136 | 90.4% | |
| AF007 | 2019 | 130 | 138 | 94.2% | |
| AF007 | 2020 | 137 | 141 | 97.2% | |
| AF007 | 2021 | 137 | 143 | 95.8% | |
| AF007 | 2022 | 141 | 143 | 98.6% | |
| AF007 | 2023 | 146 | 147 | 99.3% |
